<?xml version="1.0" encoding="UTF-8"?>
<p>During the study period, clinical cases were identified using World Health Organization (WHO) guidelines using clinical symptoms and/or positive NS1 or serology (presence of IgM or IgG) [
 <xref rid="pntd.0007504.ref033" ref-type="bibr">33</xref>]. Diagnosis of severe dengue was based on identifying more serious symptoms including severe plasma leakage, severe haemorrhage and severe organ dysfunction [
 <xref rid="pntd.0007504.ref034" ref-type="bibr">34</xref>]. From 2014 onwards, Malaysian national notification guidelines were modified, in line with WHO advice, to require a positive laboratory diagnostic test (either NS1 and/or IgM/IgG serology) in addition to the presence of clinical symptoms, and case notification within 24 hours of diagnosis [
 <xref rid="pntd.0007504.ref014" ref-type="bibr">14</xref>, 
 <xref rid="pntd.0007504.ref035" ref-type="bibr">35</xref>]. Therefore, the majority of cases prior to 2014 were clinically diagnosed (with 30–50% per year confirmed by laboratory tests in our dataset), while cases from 2014–2016 were 100% laboratory confirmed.
</p>
